Platform Technology Partners Vertex Pharmaceuticals Inc Transaction History

Platform Technology Partners

$312 Million
Q4 2024

A detailed history of Platform Technology Partners transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Platform Technology Partners holds 1,265 shares of VRTX stock, worth $621,924. This represents 0.16% of its overall portfolio holdings.

Number of Shares

1,265

Previous 1,266 0.08%

Holding current value

$621,924

Previous $588,000 13.44%

% of portfolio

0.16%

Previous 0.19%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	SELL	$396.64 - $516.74 $396 - $516	-1 Reduced 0.08%	1,265 $509,000
Q3 2024 Nov 04, 2024	SELL	$460.0 - $505.78 $41,400 - $45,520	-90 Reduced 6.64%	1,266 $588,000
Q2 2024 Jul 30, 2024	SELL	$392.81 - $485.53 $8,249 - $10,196	-21 Reduced 1.53%	1,356 $635,000
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $17,150 - $20,534	-50 Reduced 3.5%	1,377 $560,000
Q2 2023 Jul 12, 2023	SELL	$314.42 - $351.91 $6,602 - $7,390	-21 Reduced 1.45%	1,427 $502,000
Q1 2023 Apr 04, 2023	SELL	$283.23 - $323.1 $36,819 - $42,003	-130 Reduced 8.24%	1,448 $456,000
Q3 2022 Oct 24, 2022	SELL	$273.83 - $305.53 $12,870 - $14,359	-47 Reduced 2.89%	1,578 $457,000
Q2 2022 Aug 04, 2022	SELL	$234.96 - $292.55 $6,343 - $7,898	-27 Reduced 1.63%	1,625 $458,000
Q1 2022 May 03, 2022	SELL	$221.42 - $260.97 $6,642 - $7,829	-30 Reduced 1.78%	1,652 $431,000
Q4 2021 Feb 01, 2022	SELL	$177.01 - $223.45 $15,753 - $19,887	-89 Reduced 5.03%	1,682 $369,000
Q3 2021 Nov 04, 2021	BUY	$181.39 - $202.99 $2,358 - $2,638	13 Added 0.74%	1,771 $321,000
Q2 2021 Aug 05, 2021	SELL	$187.49 - $221.1 $2,062 - $2,432	-11 Reduced 0.62%	1,758 $354,000
Q4 2020 Feb 09, 2021	BUY	$207.01 - $276.09 $68,520 - $91,385	331 Added 23.02%	1,769 $418,000
Q3 2020 Nov 30, 2020	BUY	$255.65 - $303.1 $4,601 - $5,455	18 Added 1.27%	1,438 $391,000
Q2 2020 Nov 30, 2020	BUY	$225.48 - $295.8 $1,127 - $1,479	5 Added 0.35%	1,420 $412,000
Q1 2020 Nov 30, 2020	BUY	$199.77 - $247.81 $39,954 - $49,562	200 Added 16.46%	1,415 $337,000
Q4 2019 Dec 03, 2020	BUY	$166.71 - $223.91 $202,552 - $272,050	1,215 New	1,215 $266,000

Others Institutions Holding VRTX

# of Institutions

1,757

Shares Held

228M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $126B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

News

Stay updated on Platform Technology Partners with notifications on news.

Account

Platform Technology Partners Vertex Pharmaceuticals Inc Transaction History